Clinical Trial Update: The Safety and Efficacy of Multiple-dose of WJ01024 in Subject With Advanced Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating multiple doses of WJ01024 in patients with advanced cancer was terminated; the study assessed safety and efficacy in hematolog…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancies
• Solid Tumors

Drugs mentioned

• WJ01024

Snippet

Sponsor: Suzhou Junjing BioSciences Co., Ltd. | Conditions: Advanced Hematologic Malignancies, Advanced Solid Tumors | Phase 1 | Status: TERMINATED